Vincent Favaudon Selected Research

Vincent Favaudon Research Topics

Disease

14	Neoplasms (Cancer) 02/2024 - 01/2002
3	Hypoxia (Hypoxemia) 02/2024 - 05/2007
3	Breast Neoplasms (Breast Cancer) 04/2010 - 05/2007
1	Hyperthermia 10/2020
1	Lymphoma (Lymphomas) 03/2020
1	Lethargy 03/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Mucositis 01/2019
1	Adenocarcinoma 01/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Liver Neoplasms (Liver Cancer) 08/2014
1	Hepatocellular Carcinoma (Hepatoma) 08/2014
1	Fibrosis (Cirrhosis) 07/2014
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2010
1	Prostatic Neoplasms (Prostate Cancer) 03/2010
1	Glioblastoma (Glioblastoma Multiforme) 01/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2008
1	Carcinoma (Carcinomatosis) 12/2005
1	Hypersensitivity (Allergy) 10/2005
1	Genomic Instability 06/2005

Drug/Important Bio-Agent (IBA)

3	Protons (Proton)IBA 03/2020 - 11/2011
3	Radiation-Sensitizing AgentsIBA 01/2016 - 04/2007
2	Phosphotransferases (Kinase)IBA 01/2016 - 10/2005
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2014 - 03/2006
2	DNA (Deoxyribonucleic Acid)IBA 11/2011 - 06/2005
2	Estrogens (Estrogen)FDA Link 04/2008 - 05/2007
1	Phospholipids (Phosphatides)FDA LinkGeneric 02/2024
1	OxylipinsIBA 02/2024
1	Free RadicalsIBA 02/2024
1	Docosahexaenoic AcidsIBA 02/2024
1	Oxygen (Dioxygen)IBA 12/2020
1	Photosensitizing Agents (Photosensitizers)IBA 10/2020
1	TitaniumIBA 10/2020
1	Vaccine AdjuvantsIBA 10/2020
1	BismuthIBA 10/2020
1	Temazepam (Nocturne)FDA LinkGeneric 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	AfatinibIBA 01/2016
1	CarbonIBA 09/2014
1	veliparibIBA 08/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2014
1	Protein Kinases (Protein Kinase)IBA 04/2010
1	AndrogensIBA 03/2010
1	bicalutamide (Casodex)FDA LinkGeneric 03/2010
1	Histones (Histone)IBA 01/2010
1	Bromodeoxyuridine (BrdU)IBA 01/2010
1	ElementsIBA 04/2008
1	RNA Polymerase II (RNA Polymerase B)IBA 04/2008
1	Messenger RNA (mRNA)IBA 04/2008
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 04/2008
1	CCAAT-Enhancer-Binding Protein-alphaIBA 04/2008
1	Transcription Factors (Transcription Factor)IBA 04/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2008
1	Imatinib Mesylate (Gleevec)FDA Link 02/2008
1	Estrogen ReceptorsIBA 05/2007
1	Estrogen Receptor alphaIBA 05/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2007
1	1- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazeneIBA 04/2007
1	WortmanninIBA 10/2005
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 06/2005
1	RPR 130401IBA 01/2002
1	Lamin Type B (Lamin B)IBA 01/2002
1	TransferasesIBA 01/2002

Therapy/Procedure

10	Radiotherapy 09/2021 - 03/2006
1	Immunotherapy 10/2020
1	Precision Medicine 10/2020
1	Hair Removal (Depilation) 01/2019
1	Therapeutics 09/2014
1	Chemoradiotherapy 12/2005